James J. MacDonald's most recent trade in Sana Biotechnology Inc was a trade of 66,796 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 13, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Sana Biotechnology Inc | James J. MacDonald | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2022 | 66,796 | 51,954 | - | - | Stock Option (Right to Buy) | |
Sana Biotechnology Inc | James J. MacDonald | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.48 per share. | 13 Jun 2022 | 66,796 | 497,396 | - | 1.5 | 98,858 | Common Stock |
Sana Biotechnology Inc | James J. MacDonald | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 4.28 per share. | 13 Jun 2022 | 1,183 | 430,600 | - | 4.3 | 5,068 | Common Stock |
Sana Biotechnology Inc | James J. MacDonald | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 225,000 | 225,000 | - | - | Stock Options (Right to Buy) | |
Sana Biotechnology Inc | James J. MacDonald | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 18.23 per share. | 18 Feb 2022 | 1,000 | 429,750 | - | 18.2 | 18,233 | Common Stock |
Sana Biotechnology Inc | James J. MacDonald | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 6.28 per share. | 18 Feb 2022 | 333 | 429,417 | - | 6.3 | 2,091 | Common Stock |
Sana Biotechnology Inc | James J. MacDonald | See Remarks | 08 Feb 2021 | 93,750 | 0 | - | - | Series A-1 Convertible Preferred Stock | ||
Sana Biotechnology Inc | James J. MacDonald | See Remarks | 08 Feb 2021 | 93,750 | 428,750 | - | - | Common Stock | ||
Sana Biotechnology Inc | James J. MacDonald | See Remarks | 08 Feb 2021 | 7,812 | 7,812 | - | - | Common Stock | ||
Sana Biotechnology Inc | James J. MacDonald | See Remarks | 08 Feb 2021 | 7,812 | 0 | - | - | Series B Convertible Preferred Stock |